New therapeutic evidence has demonstrated that umbilical cord-derived mesenchymal stem cells (MSCs) can safely and effectively improve motor and comprehensive function in children with cerebral palsy (CP).
At only four years old, Henrique is the first person in Portugal to receive an infusion of his own cord blood stem cells, in what’s known as an autologous cord blood transplant. The stem cells were used to successfully put Henrique in remission from severe aplastic anaemia.
A recently published paper in the Stem Cell Research & Therapy medical journal shows that umbilical cord tissue can provide large volumes of stem cells over a prolonged period. In theory, this means that people with stored cord tissue could have more stem cells available to them for multiple treatments.
A three-year-old girl has received treatment for cerebral palsy (CP), using her baby brother’s cord blood stem cells. The sample was taken from their mother’s umbilical cord at birth and stored with Future Health Biobank, at our Swiss storage facility.
1 in 400 children are diagnosed with cerebral palsy (CP) – a condition caused by brain development problems before, during or soon after birth. Although there is no single treatment yet, growing evidence suggests that certain types of stem cells could help treat the symptoms of CP.